Xpreza 200mg Tab (Azacitidine Tablet) 200 mg

Xpreza 200mg Tab contains azacitidine, a chemotherapy medication used for certain blood cancers. This 200 mg tablet form is designed for oral administration in cancer therapy. Store at room temperature and follow healthcare provider guidance for use. Always consult a medical professional before starting treatment.

Strength

200 mg

Pack Size

14s

Storage

Ambient

Manufacturer / TM Owner

BDR Pharmaceuticals Intl Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Azacitidine is prescribed to treat myelodysplastic syndromes and acute myeloid leukemia in adults. It works by helping the bone marrow produce normal blood cells. Patients with specific blood cancer diagnoses may receive this medication as part of their treatment plan. Always use as directed by a healthcare provider.

Side Effects

Common effects of azacitidine include nausea, fatigue, and injection site reactions when used as directed. Some patients may experience changes in blood cell counts during treatment. These effects vary by individual and should be monitored regularly.

Precautions & Warnings

Keep Xpreza 200mg Tab in its original packaging until ready to use. Store at room temperature away from moisture and heat. Handle with care and avoid contact with skin or eyes. Always wash hands after handling the medication.

Avoid Interactions

Azacitidine may interact with other medications affecting blood cell counts or liver function. Alcohol and certain herbal supplements could influence its effects. Inform your healthcare provider about all medications and supplements you are taking before starting treatment.

References

Frequently Asked Questions

Xpreza 200mg Tab is used to treat certain types of blood cancers, including myelodysplastic syndromes and acute myeloid leukemia.

Store Xpreza 200mg Tab at room temperature in its original packaging, away from moisture and heat.

Consult your healthcare provider before combining Xpreza 200mg Tab with other medications or supplements to avoid potential interactions.

Common side effects may include nausea, fatigue, and changes in blood cell counts, which should be monitored by a healthcare provider.

Yes, Xpreza 200mg Tab contains azacitidine, which is a chemotherapy medication used in cancer treatment.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.